Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy CoROCO:6469 -0.14%69 Return-on-Tangible-Asset is 3.66% as of Mar. 2026, which is 39% below its 10-year median of 6.04. GuruFocus rates ROCO:6469 with a GF Score™ of 69/100 and a GF Value™ of NT$168.48 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks better than 57.88% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Great Tree Pharmacy Co's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$501 Mil. Great Tree Pharmacy Co's average total tangible assets for the quarter that ended in Mar. 2026 was NT$13,672 Mil. Therefore, Great Tree Pharmacy Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 3.66%.
The historical rank and industry rank for Great Tree Pharmacy Co's Return-on-Tangible-Asset or its related term are showing as below:
ROCO:6469'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 3.65 Med: 6.04 Max: 8.65
Current: 4.28
During the past 13 years, Great Tree Pharmacy Co's highest Return-on-Tangible-Asset was 8.65%. The lowest was 3.65%. And the median was 6.04%.
ROCO:6469's Return-on-Tangible-Asset is ranked better than 57.88% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs ROCO:6469: 4.28
Great Tree Pharmacy Co (ROCO:6469) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Great Tree Pharmacy Co Return-on-Tangible-Asset Related Terms
Great Tree Pharmacy Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Great Tree Pharmacy Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co Return-on-Tangible-Asset Chart
Great Tree Pharmacy Co Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 3.66% mean?
Great Tree Pharmacy Co (ROCO:6469) has a Return-on-Tangible-Asset of 3.66% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Great Tree Pharmacy Co and its competitors. This is 39% below median its historical median of 6.04. Over the past decade, Great Tree Pharmacy Co's Return-on-Tangible-Asset has ranged from 3.65 to 8.65. According to the industry distribution chart, Great Tree Pharmacy Co ranks #286 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 42.1%.
Is Great Tree Pharmacy Co's Return-on-Tangible-Asset too high?
Great Tree Pharmacy Co's current Return-on-Tangible-Asset of 3.66% is 39% below median its 10-year median of 6.04. Over the past 10 years, this metric has ranged from a low of 3.65 to a high of 8.65. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Great Tree Pharmacy Co's value of 3.66% is 45.8% above this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #286 out of 679 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #286 out of 679 companies for Return-on-Tangible-Asset. This puts Great Tree Pharmacy Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.51. Great Tree Pharmacy Co's value of 3.66% is 45.8% above this benchmark. Historically, Great Tree Pharmacy Co's own Return-on-Tangible-Asset has ranged from 3.65 to 8.65 over the past decade. While the company's 10-year median is 6.04 vs. the industry median of 2.51, Great Tree Pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current Return-on-Tangible-Asset of 3.66% is 45.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current Return-on-Tangible-Asset is 3.66%, which is 39% below median its own 10-year median of 6.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$168.48, compared to a current price of NT$70.10 — trading 58.4% below its estimated fair value. The current Return-on-Tangible-Asset is 3.66%, which is 39% below median its 10-year median of 6.04 and 45.8% above the Healthcare Providers & Services industry median of 2.51. Great Tree Pharmacy Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current Return-on-Tangible-Asset is 3.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$70.10 is trading 58.4% below its estimated GF Value™ of NT$168.48.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
Return-on-Tangible-Asset: 3.66% (39% below median its 10-year median of 6.04)
GF Value™: NT$168.48 vs. price of NT$70.10 (58.4% below fair value)
Industry Position: 45.8% above the Healthcare Providers & Services median (#286 of 679)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
69GF Score
Get the complete analysis for ROCO:6469
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
